Pirfenidone

Drug Details

Pirfenidone, marketed under the brand name Esbriet, is an antifibrotic medication prescribed for adults with idiopathic pulmonary fibrosis (IPF), a serious lung condition characterized by scarring that leads to stiffness and difficulty in breathing. While the exact mechanism is not fully understood, Pirfenidone is believed to slow down the progression of IPF by reducing lung inflammation and scarring. The treatment is taken orally three times a day with food, starting with a low dose that is gradually increased. Common side effects may include nausea, stomach pain, and skin rash. Due to potential liver complications, regular liver function tests are necessary. Both brand-name and generic versions are available. Always consult your healthcare provider for personalized medical advice before starting any new medication.